Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296671 | 1.00 | TRPA1 (0.38) | TRPA1 | |
| SCHEMBL1287812 | 0.78 | — | — | |
| SCHEMBL8343222 | 0.78 | — | — | |
| SCHEMBL18425121 | 0.77 | ALOX15 (0.39) | TRPA1 | |
| SCHEMBL14060452 | 0.77 | ALOX15 (0.39) | TRPA1 | |
| SCHEMBL14060451 | 0.77 | ALOX15 (0.39) | TRPA1 | |
| SCHEMBL14146580 | 0.77 | ALOX15 (0.39) | TRPA1 | |
| SCHEMBL566898 | 0.76 | — | — | |
| SCHEMBL566899 | 0.76 | — | — | |
| SCHEMBL29216379 | 0.76 | TRPA1 (0.37) | TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| WO-2021050786-A1 | CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. (US) | 2021-03-18 | — | — | WO | claimed |
| US-20210068444-A1 | CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. | 2021-03-11 | — | — | US | claimed |
| US-7678870-B2 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY (US) | 2010-03-16 | — | — | US | claimed |
| US-20070197746-A1 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY | 2007-08-23 | — | — | US | claimed |
| EP-1733211-A4 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | UNIV JOHNS HOPKINS (US) | 2007-05-30 | — | — | EP | claimed |
| EP-1733211-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS-HOPKINS UNIVERSITY (US) | 2006-12-20 | — | — | EP | claimed |
| WO-2005103655-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2005-11-03 | — | — | WO | claimed |
| EP-0037584-B1 | 2,4-DIALKYL-2,6-HEPTADIENALS AND -HETADIENOLS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PERFUME COMPOUNDS AND FLAVOURINGS | Consortium für elektrochemische Industrie GmbH (DE) | 1983-11-16 | — | — | EP | claimed |
| US-4380675-A | 2,4-Dialkyl-2,6-heptadienal derivatives, a process for their preparation, and fragrant and flavoring products made therewith | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1983-04-19 | — | — | US | claimed |
| US-20250044289-A1 | MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIODETECTION | ORCA HOLDINGS LLC (US) | 2025-02-06 | — | — | US | disclosed |
| US-20240327232-A1 | METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL | OMYA INTERNATIONAL AG (CH) | 2024-10-03 | — | — | US | disclosed |
| US-20240181430-A1 | POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF | MEMORIAL UNIVERSITY OF NEWFOUNDLAND (CA) | 2024-06-06 | — | — | US | disclosed |
| EP-4294559-A1 | POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF | Memorial University of Newfoundland (CA) | 2023-12-27 | — | — | EP | disclosed |
| US-5637757-A | REACTING TETRABROMOPHTHALIC ANHYDRIDE WITH AN ALCOHOL IN PRESENCE OF A DECARBOXYLATION CATALYST | GREAT LAKES CHEMICAL CORPORATION (US) | 1997-06-10 | — | — | US | disclosed |
| US-5630978-A | POLYMERIZATION OF FUNCTIONAL MONOMERS AROUND A BIOLOGICALLY ACTIVE TEMPLATE MOLECULE, REMOVAL OF TEMPLATE TO LEAVE A VOID, THEN POLYMERIZATION OF OTHER MONOMER(S) IN THE VOID | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1997-05-20 | — | — | US | disclosed |
| EP-0037584-B1 | 2,4-DIALKYL-2,6-HEPTADIENALS AND -HETADIENOLS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PERFUME COMPOUNDS AND FLAVOURINGS | Consortium für elektrochemische Industrie GmbH (DE) | 1983-11-16 | — | — | EP | disclosed |
| US-4380675-A | 2,4-Dialkyl-2,6-heptadienal derivatives, a process for their preparation, and fragrant and flavoring products made therewith | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1983-04-19 | — | — | US | disclosed |
| EP-0037584-A1 | 2,4-Dialkyl-2,6-heptadienals and -hetadienols, process for their preparation and their use as perfume compounds and flavourings | Consortium für elektrochemische Industrie GmbH (DE) | 1981-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | TRPA1 2636/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | TRPA1 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.